Drugs / AFP adenoviral vector
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00669136 | Jun 2009 → Mar 2013 | adult hepatocellular carcinoma | Lisa H. Butterfield, Ph.D. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AFP adenoviral vector | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00669136 ↗ |
| Known as | AdVhAFP | “an AFP adenoviral vector (AdVhAFP)” NCT00669136 ↗ |
| Route | Intramuscular | “a single intramuscular boost with an AFP adenoviral vector” NCT00669136 ↗ |